hum0163 Release Note
| Research ID | Release Date | Type of Data |
|---|---|---|
| hum0163.v3 | 2023/04/21 | GWAS for bullous pemphigoid |
| hum0163.v2 | 2021/02/09 | NGS (NAT2 haplotype) |
| hum0163.v1 | 2018/12/14 | NGS (Target Capture) |
hum0163.v3
DNAs extracted from peripheral blood cells of bullous pemphigoid patients and B-lymphoblast cells were genotyped by using of Illumina Infinium OmniExpressExome BeadChip and a genome-wide association study was performed (xlsx file).
hum0163.v2
Genotype frequencies of NAT2 identified from the targeted capture sequencing (NGS) analysis were provided (csv file).
hum0163.v1
DNAs extracted from peripheral blood cells of patients with psychiatric/neurological disorders or cancers were used for the targeted NGS analysis focusing on 100 pharmacogenes and CYP2D6. Allele frequencies of 100 pharmacogenes (1846 variants) and genotype frequencies of CYP2D6 for 990 patients were provided (csv file).
Libraries were prepared by using of in-house multiplexPCR and read by Illumina [MiSeq] (paired-end: average read length 377 bp).
Note:
